Samsara Vision

Samsara Vision

Private
New JerseyHealthcare & Life Scienceshttps://www.samsaravision.com

Last Round

Convertible Debt

Mar 16, 2021

Total Funding Raised

$104.7M

Company Overview

Samsara Vision is a specialty medical device company that develops, manufactures, and markets implantable ophthalmic devices for patients with late-stage retinal disorders. The company's primary technology is the Implantable Miniature Telescope (IMT), a prosthetic device designed to improve vision and quality of life for individuals with the most advanced form of age-related macular degeneration (AMD). Its first-generation product is FDA-approved, and its next-generation device, the SING IMT™, is approved in Europe and undergoing clinical trials in the United States. The company was formerly known as VisionCare, Inc. and changed its name in September 2020. It is headquartered in the U.S. with research and development operations in Israel.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Patient Engagement

Business Model

B2B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

implantable miniature telescopeIMTlate-stage AMDtelescopic eye implantage-related macular degenerationmacular degeneration implantophthalmic implantvision restorationcentral blind spotSING IMTFDA approved medical deviceCentraSightMedicare reimbursementretinal disordersCE Mark

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Samsara Vision Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Samsara Vision Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtMar 16, 2021
DebtSep 17, 2013
Series EJan 10, 2011
Series DJan 7, 2005
Series CNov 7, 2003
Series A
Dec 1, 1999

Key People

Founding team and executive leadership

Joshua Fox

Chief Financial Officer

Executive Team

Samsara Vision Investors

Notable investors and investment history

InvestorRounds
Saints CapitalSeries E
Peregrine VenturesSeries A
Pitango Venture CapitalSeries E, Series C, Series A, Series D
ONSET VenturesSeries E, Series D, Series C
Life Sciences Alternative FundingDebt

Samsara Vision Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Samsara Vision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Samsara Vision's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Jersey
Employee Range41
Year Founded1997
Last FundingMar 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.